Skip to main content
OpenTrials

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

194 public trials 80 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

NCT06500273

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
  • Alta Bates Summit Medical Center Berkeley, California, United States
  • City of Hope Duarte, California, United States
View all 82 locations
View Trial Details
Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

NCT07211178

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Birmingham Hematology Associates Birmingham, Alabama, United States
  • PIH Health Whittier Hospital Whittier, California, United States
  • Cleveland Clinic Florida Weston, Florida, United States
  • Southern Illinois Hospital Services Carbondale, Illinois, United States
View all 14 locations
View Trial Details

Related conditions